AgomAb Therapeutics AGMB SEC Filings

NASDAQ AGMB
$8.90 -0.21 (-2.31%)
As of: Oct 22, 2026 · 12:53 PM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing AgomAb Therapeutics NV (AGMB) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
14Insider Transaction0001445826-26-000013Oct 7, 2026 4:57 PM
24Insider Transaction0002119332-26-000001Oct 7, 2026 4:47 PM
34Insider Transaction0002120886-26-000001Oct 7, 2026 4:06 PM
46-KCurrent Report0001104659-26-112564Oct 1, 2026 6:42 AM
54Insider Transaction0001104659-26-107916Sep 15, 2026 8:06 PM
64Insider Transaction0001104659-26-107915Sep 15, 2026 8:06 PM
73Insider Transaction0001104659-26-107914Sep 15, 2026 8:05 PM
83Insider Transaction0001104659-26-107912Sep 15, 2026 8:05 PM
96-KCurrent Report0001104659-26-107500Sep 14, 2026 8:14 PM
106-KCurrent Report0001104659-26-107117Sep 11, 2026 5:02 PM
116-KCurrent Report0001104659-26-093390Aug 10, 2026 4:17 PM
126-KCurrent Report0001104659-26-091992Aug 6, 2026 8:06 PM
136-KCurrent Report0001104659-26-076819Jun 23, 2026 8:13 PM
146-KCurrent Report0001104659-26-066590May 27, 2026 7:12 AM-
15SCHEDULE 13GBeneficial Ownership Report0001104659-26-062718May 15, 2026 8:45 PM
16SCHEDULE 13GBeneficial Ownership Report0001172661-26-002216May 15, 2026 5:14 PM
17SCHEDULE 13GBeneficial Ownership Report0001193125-26-207455May 6, 2026 10:00 AM
18SCHEDULE 13GBeneficial Ownership Report0001193125-26-207455May 6, 2026 10:00 AM
19SCHEDULE 13GBeneficial Ownership Report0001193125-26-207455May 6, 2026 10:00 AM
206-KCurrent Report0001104659-26-048615Apr 24, 2026 8:22 PM
2120-FQuarterly & Annual Report0001104659-26-047872Apr 23, 2026 9:17 PM
22SCHEDULE 13GBeneficial Ownership Report0001213900-26-044365Apr 16, 2026 1:14 PM
23SCHEDULE 13GBeneficial Ownership Report0001213900-26-044365Apr 16, 2026 1:14 PM
24SCHEDULE 13GBeneficial Ownership Report0001213900-26-044365Apr 16, 2026 1:14 PM
253Insider Transaction0001104659-26-030839Mar 18, 2026 8:01 PM
263Insider Transaction0001104659-26-030839Mar 18, 2026 8:01 PM
273Insider Transaction0001104659-26-030839Mar 18, 2026 8:01 PM
283Insider Transaction0001104659-26-030843Mar 18, 2026 8:01 PM
293Insider Transaction0001104659-26-030843Mar 18, 2026 8:01 PM
303Insider Transaction0001104659-26-030843Mar 18, 2026 8:01 PM
313Insider Transaction0001104659-26-030838Mar 18, 2026 8:01 PM
323Insider Transaction0001104659-26-030838Mar 18, 2026 8:01 PM
333Insider Transaction0001104659-26-030838Mar 18, 2026 8:01 PM
343Insider Transaction0001104659-26-030840Mar 18, 2026 8:01 PM
353Insider Transaction0001104659-26-030840Mar 18, 2026 8:01 PM
363Insider Transaction0001104659-26-030840Mar 18, 2026 8:01 PM
373Insider Transaction0001104659-26-030842Mar 18, 2026 8:01 PM
383Insider Transaction0001104659-26-030842Mar 18, 2026 8:01 PM
393Insider Transaction0001104659-26-030842Mar 18, 2026 8:01 PM
403Insider Transaction0001104659-26-030841Mar 18, 2026 8:01 PM
413Insider Transaction0001104659-26-030841Mar 18, 2026 8:01 PM
423Insider Transaction0001104659-26-030841Mar 18, 2026 8:01 PM
433Insider Transaction0001104659-26-030835Mar 18, 2026 8:01 PM
443Insider Transaction0001104659-26-030835Mar 18, 2026 8:01 PM
453Insider Transaction0001104659-26-030835Mar 18, 2026 8:01 PM
463Insider Transaction0001104659-26-030836Mar 18, 2026 8:01 PM
473Insider Transaction0001104659-26-030836Mar 18, 2026 8:01 PM
483Insider Transaction0001104659-26-030836Mar 18, 2026 8:01 PM
493Insider Transaction0001104659-26-030834Mar 18, 2026 8:01 PM
503Insider Transaction0001104659-26-030834Mar 18, 2026 8:01 PM

AgomAb Therapeutics NV SEC Filings API

Pull AgomAb Therapeutics NV's SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=AGMB&formtype=10-K,10-Q&api_key=YOUR_API_KEY